April 20, 2010 - Phenomix Announces Positive Results from a Phase 3 Study of Dutogliptin in Type 2 Diabetes Mellitus
October 28, 2008 - Phenomix Initiates Phase 1a Clinical Trial of Hepatitis C Protease Inhibitor PHX1766 [READ MORE]
October 23, 2008 - Phenomix and Forest Laboratories to Collaborate on Development and Commercialization of Dutogliptin in Diabetes [READ MORE]